Trademark: 97022225
Word
SAMSCA (TOLVAPTAN)
Status Date
Tuesday, November 1, 2022
Registration Number
6888096
Registration Date
Tuesday, November 1, 2022
Filing Date
Friday, September 10, 2021
Published for Opposition
Tuesday, August 16, 2022
5 Pharmaceutical preparations for the treatment of hyponatremia, in patients with Syndrome of Inappropriate Antidiuretic Hormone (SIADH), heart failure and cirrhosis, namely, Tolvaptan
The mark consists of "SAMSCA" in a stylized, orange font with white outlining centered over an image of a blue liquid droplet with white highlights and details. The term "TOLVAPTAN" is in white lowercase font within parentheses and appears centered beneath "SAMSCA". All other white in the drawing is merely background and is not claimed as part of the mark.
The color(s) blue, orange, and white is/are claimed as a feature of the mark.
"TOLVAPTAN"
Nov 1, 2022
Notice Of Registration Confirmation Emailed
Nov 1, 2022
Registered-Principal Register
Aug 16, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 16, 2022
Published For Opposition
Jul 27, 2022
Notification Of Notice Of Publication E-Mailed
Jul 12, 2022
Approved For Pub - Principal Register
Jul 9, 2022
Teas/Email Correspondence Entered
Jul 8, 2022
Correspondence Received In Law Office
Jul 8, 2022
Teas Response To Office Action Received
Apr 28, 2022
Notification Of Priority Action E-Mailed
Apr 28, 2022
Priority Action E-Mailed
Apr 28, 2022
Priority Action Written
Apr 25, 2022
Assigned To Examiner
Oct 20, 2021
Notice Of Design Search Code E-Mailed
Oct 19, 2021
New Application Office Supplied Data Entered In Tram
Sep 14, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
